Please login to the form below

Not currently logged in
Email:
Password:

Kim Lemon appointed head of Liberation Unlimited

Will lead rebrand of Communiqué award-winning agency
Kim Lemon, Liberation

Liberation Unlimited has named former associate director Kim Lemon as its new head.

The announcement comes a few weeks after Liberation Communications changed its name to Liberation Unlimited as part of a rebrand of its parent group Creston Health, which is now known as Health Unlimited.

Lemon spent five years as associate director at Liberation having joined the company in 2009 from Athena Medical PR where she served as senior account manager. She also has experience in industry at the Johnson & Johnson subsidiary Lifescan.

Catherine Warne, CEO of Health Unlimited said: “Over the last year, and particularly in the last five months, Kim has become a figurehead for the agency.

“She has taken the lead on the development of a strong business plan for the agency, the roll-out of Liberation Unlimited and completely fresh branding, which will be launched in the New Year.” 

During her time at Liberation Lemon helped the agency to the Small Consultancy or Health Team of the Year award at the 2014 Communiqué Awards. She also led the PR team that won the Cello Health Award for Launch Excellence at the recent PMEA for its work on Bayer's Eylea.

11th December 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics